← Open Payments lookup

GULZAR BALICH: Open Payments

NPI 1962026054 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,192 in 42 payments from 11 companies in 2025. Trend: 2023 $732 · 2024 $1,609 · 2025 $1,192

Food & beverage: $1,192
CompanyPaymentsAmount
Bayer Healthcare Pharmaceuticals Inc.15$381
AstraZeneca Pharmaceuticals LP7$249
Merck Sharp & Dohme LLC6$130
Boehringer Ingelheim Pharmaceuticals, Inc.1$125
Novartis Pharmaceuticals Corporation5$112
Amgen Inc.3$54
PFIZER INC.1$39
Alnylam Pharmaceuticals Inc.1$37
BridgeBio Pharma, Inc.1$26
Biogen, Inc.1$22

Products named: Kerendia, WAINUA, VERQUVO, JARDIANCE, LEQVIO, REPATHA, ELIQUIS, AMVUTTRA.

Industry payments across NY — which companies pay providers there.